VIA
HZNP
Vident Investment Advisory’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,833
| Closed | -$527K | – | 1369 |
|
|
2023
Q1 | $527K | Sell |
4,833
-98,257
| -95% | -$10.7M | 0.02% | 759 |
|
|
2022
Q4 | $11.7M | Buy |
103,090
+21,355
| +26% | +$2.43M | 0.44% | 43 |
|
|
2022
Q3 | $5.05M | Buy |
81,735
+17,593
| +27% | +$1.09M | 0.16% | 164 |
|
|
2022
Q2 | $5.12M | Buy |
64,142
+9,803
| +18% | +$782K | 0.15% | 168 |
|
|
2022
Q1 | $5.72M | Buy |
54,339
+14,845
| +38% | +$1.56M | 0.15% | 160 |
|
|
2021
Q4 | $4.26M | Buy |
39,494
+6,196
| +19% | +$668K | 0.11% | 209 |
|
|
2021
Q3 | $3.65M | Sell |
33,298
-1,917
| -5% | -$210K | 0.11% | 188 |
|
|
2021
Q2 | $3.3M | Buy |
35,215
+27,356
| +348% | +$2.56M | 0.1% | 217 |
|
|
2021
Q1 | $724K | Buy |
7,859
+400
| +5% | +$36.8K | 0.02% | 695 |
|
|
2020
Q4 | $545K | Sell |
7,459
-1,814
| -20% | -$133K | 0.02% | 693 |
|
|
2020
Q3 | $720K | Buy |
+9,273
| New | +$720K | 0.04% | 579 |
|
|
2016
Q4 | – | Sell |
-24,351
| Closed | -$441K | – | 401 |
|
|
2016
Q3 | $441K | Sell |
24,351
-54,890
| -69% | -$994K | 0.06% | 378 |
|
|
2016
Q2 | $1.31M | Sell |
79,241
-163,369
| -67% | -$2.69M | 0.18% | 253 |
|
|
2016
Q1 | $4.02K | Buy |
242,610
+61,948
| +34% | +$1.03K | 0.25% | 201 |
|
|
2015
Q4 | $3.92M | Sell |
180,662
-78,463
| -30% | -$1.7M | 0.5% | 8 |
|
|
2015
Q3 | $5.14M | Buy |
259,125
+142,173
| +122% | +$2.82M | 0.71% | 6 |
|
|
2015
Q2 | $4.06M | Buy |
116,952
+43,849
| +60% | +$1.52M | 0.54% | 12 |
|
|
2015
Q1 | $1.9M | Buy |
+73,103
| New | +$1.9M | 0.38% | 27 |
|